EAM
ABBV icon

Evanson Asset Management’s AbbVie ABBV Stock Holding History

Evanson Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$854K Sell
3,925
-395
-9% -$87.6K 0.05% 148
2025
Q4 		$987K Hold
4,320
– – 0.05% 140
2025
Q3 		$1M Sell
4,320
-1,511
-26% -$308K 0.06% 141
2025
Q2 		$1.08M Buy
5,831
+1,550
+36% +$288K 0.07% 128
2025
Q1 		$897K Buy
4,281
+757
+21% +$147K 0.06% 132
2024
Q4 		$626K Hold
3,524
– – 0.04% 157
2024
Q3 		$696K Sell
3,524
-139
-4% -$25.9K 0.05% 142
2024
Q2 		$628K Sell
3,663
-38
-1% -$6.29K 0.05% 148
2024
Q1 		$674K Sell
3,701
-167
-4% -$28.8K 0.05% 147
2023
Q4 		$599K Hold
3,868
– – 0.05% 153
2023
Q3 		$577K Buy
3,868
+48
+1% +$7.05K 0.05% 144
2023
Q2 		$515K Hold
3,820
– – 0.05% 157
2023
Q1 		$609K Hold
3,820
– – 0.06% 133
2022
Q4 		$617K Sell
3,820
-413
-10% -$63.3K 0.07% 130
2022
Q3 		$568K Sell
4,233
-101
-2% -$14.5K 0.07% 133
2022
Q2 		$664K Sell
4,334
-248
-5% -$37.9K 0.07% 121
2022
Q1 		$743K Sell
4,582
-494
-10% -$71.8K 0.07% 125
2021
Q4 		$687K Sell
5,076
-2,269
-31% -$268K 0.06% 142
2021
Q3 		$825K Buy
7,345
+48
+0.7% +$5.49K 0.08% 117
2021
Q2 		$822K Sell
7,297
-298
-4% -$33.6K 0.09% 115
2021
Q1 		$822K Buy
7,595
+1,721
+29% +$184K 0.12% 106
2020
Q4 		$629K Buy
5,874
+86
+1% +$8.26K 0.1% 128
2020
Q3 		$507K Buy
5,788
+1,612
+39% +$152K 0.09% 128
2020
Q2 		$410K Sell
4,176
-30
-0.7% -$2.64K 0.08% 146
2020
Q1 		$320K Buy
4,206
+309
+8% +$26.3K 0.08% 154
2019
Q4 		$345K Buy
3,897
+288
+8% +$23.9K 0.07% 165
2019
Q3 		$273K Sell
3,609
-484
-12% -$33.2K 0.06% 193
2019
Q2 		$298K Sell
4,093
-381
-9% -$29.9K 0.06% 182
2019
Q1 		$361K Sell
4,474
-1,085
-20% -$88.8K 0.07% 156
2018
Q4 		$512K Buy
5,559
+1,048
+23% +$92.2K 0.12% 110
2018
Q3 		$427K Sell
4,511
-6,450
-59% -$612K 0.09% 144
2018
Q2 		$1.02M Buy
10,961
+41
+0.4% +$4K 0.2% 72
2018
Q1 		$1.03M Buy
10,920
+205
+2% +$22.5K 0.21% 70
2017
Q4 		$1.04M Buy
10,715
+78
+0.7% +$7.35K 0.21% 73
2017
Q3 		$945K Hold
10,637
– – 0.2% 76
2017
Q2 		$771K Sell
10,637
-100
-0.9% -$6.72K 0.18% 88
2017
Q1 		$700K Buy
10,737
+843
+9% +$53K 0.17% 89
2016
Q4 		$620K Sell
9,894
-239
-2% -$14.6K 0.17% 90
2016
Q3 		$639K Buy
10,133
+441
+5% +$28.5K 0.18% 87
2016
Q2 		$600K Sell
9,692
-171
-2% -$10.4K 0.18% 89
2016
Q1 		$563K Buy
9,863
+41
+0.4% +$2.29K 0.19% 85
2015
Q4 		$582K Buy
9,822
+242
+3% +$13.9K 0.21% 84
2015
Q3 		$521K Sell
9,580
-10,852
-53% -$706K 0.2% 98
2015
Q2 		$1.37M Buy
20,432
+499
+3% +$32.6K 0.48% 44
2015
Q1 		$1.17M Sell
19,933
-900
-4% -$54.4K 0.42% 55
2014
Q4 		$1.36M Buy
20,833
+10,425
+100% +$657K 0.5% 41
2014
Q3 		$601K Sell
10,408
-253
-2% -$14K 0.24% 81
2014
Q2 		$602K Buy
10,661
+76
+0.7% +$3.99K 0.23% 94
2014
Q1 		$544K Sell
10,585
-598
-5% -$30.2K 0.24% 93
2013
Q4 		$591K Buy
+11,183
New +$550K 0.26% 84

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Evanson Asset Management's ABBV Position: Q1 2026 in Review

Evanson Asset Management reduced its AbbVie (ABBV) stake by 9.1% in Q1 2026, selling an estimated $87.6K and leaving 3,925 shares worth $854K. The position accounts for 0.05% of the portfolio, ranked #148.

Evanson Asset Management first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.37M in Q2 2015. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Evanson Asset Management held 3,925 shares of AbbVie worth $854K as of Q1 2026.
  • Evanson Asset Management sold 395 AbbVie shares in Q1 2026, an estimated $87.6K.
  • AbbVie made up 0.05% of Evanson Asset Management's portfolio in Q1 2026, its #148 holding.
  • Evanson Asset Management first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
  • Evanson Asset Management's AbbVie position peaked at $1.37M in Q2 2015.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Evanson Asset Management's 13F filing for Q1 2026, filed 8 Apr 2026.